MedPath

Choice Switching and Autism

Completed
Conditions
Autism Spectrum Disorder (ASD)
Interventions
Diagnostic Test: Pre-screening
Behavioral: Task session
Registration Number
NCT04631432
Lead Sponsor
Technion, Israel Institute of Technology
Brief Summary

The study aims to replicate and clarify a recently observed phenomenon whereby individuals with Autism Spectrum Disorder (ASD) switch between options in a repeated task to a greater extent than healthy controls do. In a meta-analysis a large effect size was found (.37) yet because the effect was noisy in different studies it was not statistically significant. The investigators seek to first examine a very large population through an Internet mediated platform. The sample size will be about the size of all of the previous studies that examined this issue together. Secondly, the investigators wish to understand the discrepancy between this choice switching phenomenon and the recorded tendency of ASD individuals to avoid changing choices. First, the investigators will administer the task in which the effect was found (the Iowa Gambling task) for a longer duration than previously and evaluate whether ASD individuals show increased choice switching in the first blocks of trials but reduced switching following more experience. Secondly, the investigators will administer an additional block of trials without feedback in which participants will not be able to go through a learning process. The investigators predict that this will reduce (and possible flip) the tendency of individuals with ASD to switch choices more often.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
114
Inclusion Criteria
  • ASD group - Diagnosed with ASD
  • Control - No ASD diagnosis: within age and education range of the ASD group.
Exclusion Criteria
  • Demographics: Under 18 years of age.
  • Mental health: self reported brain injury and neurological disorder (besides autism).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Study participationPre-screeningAll participants will complete the same protocol
Study participationTask sessionAll participants will complete the same protocol
Primary Outcome Measures
NameTimeMethod
Mean run sizeThrough study completion, an average of 1 year

Number of consecutive selections from the same deck (across trials and in different blocks).

Advantageous selectionsThrough study completion, an average of 1 year

Percentage of advantageous selections(across trials and in different blocks).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Technion, Israel Institute of Technology

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath